Keyphrases
Benign Prostatic Hyperplasia
100%
β-sitosterol
100%
Placebo
36%
Weighted Mean Difference
27%
Flow Measuring
27%
Treatment Duration
18%
Symptom Score
18%
MEDLINE
18%
Symptomatic Benign Prostatic Hyperplasia
18%
Glucoside
18%
International Prostate Symptom Score
18%
Demographic Information
9%
Pharmacological Therapy
9%
Long-term Efficacy
9%
Randomized Trial
9%
Pharmaceutical Companies
9%
Short-term Treatment
9%
Confidence Interval
9%
Embase
9%
Urinary Symptoms
9%
Cochrane Library
9%
Urinary Flow
9%
Inclusion Criteria
9%
Urinary Flow Rate
9%
Prostate Size
9%
Plant Extracts
9%
Withdrawal Rate
9%
Residual Volume
9%
Extract Preparation
9%
Urological Symptoms
9%
Enrollment Criteria
9%
Medicine and Dentistry
Systematic Review
100%
Prostate Hypertrophy
100%
Sitosterol
100%
Placebo
44%
Urinary System
22%
International Prostate Symptom Score
22%
Treatment Duration
22%
Sitosterol Derivative
22%
Drug Therapy
11%
Demography
11%
Urine Flow Rate
11%
Residual Volume
11%
Plant Extract
11%
Sitogluside
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Hypertrophy
100%
Sitosterol
100%
Placebo
44%
Sitosterol Derivative
22%
Pharmacotherapy
11%
Sitogluside
11%
Plant Extract
11%